ISRCTN11160072已完成未知
eoadjuvant systemic therapy in breast cancer: a national prospective multicentre audit of neoadjuvant systemic therapy in breast cancer
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,283
研究概览
简要总结
2019 protocol in: https://www.ncbi.nlm.nih.gov/pubmed/31897446 (added 06/01/2020)
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
入选标准
- •1. Age > 16 years
- •2. Histologically confirmed diagnosis of breast cancer
- •3. MDT recommended treatment of neoadjuvant systemic therapy (either hormonal or chemotherapy) - including patients entering into clinical trials of neoadjuvant systemic therapy.
排除标准
- •1. Patients entering window of opportunity” clinical trials
研究者
相似试验
招募中
不适用
Neoadjuvant Endocrine Therapy in Breast Cancer. Real Clinical Practice in RussiaNeoadjuvant Endocrine TherapyBreast CancerNCT05800197Blokhin's Russian Cancer Research Center300
Unknown
不适用
Neoadjuvant Chemotherapy in Breast CancerDecision Support Systems, ClinicalNCT04802941Center of Personalized Medicine, Pirogova1,200
招募中
不适用
De-escalation of Neoadjuvant Chemotherapy Regimens With Targeted Therapy Among HER2 Positive PatientsHER2-positive Breast CancerNCT06700369Shu Wang519
招募中
1 期
Neoadjuvant Therapy Study Guided by Drug Screening in Vitro for Human Epidermal Growth Factor Receptor 2 (HER2) Negative Early Breast Cancer PatientsHER2-negative Early Breast CancerNCT04836156Peking University People's Hospital46
已完成
不适用
Clip Marker Placement in Primary Lesions of Breast Cancer Patients Receiving Neoadjuvant TherapyPrimary Breast CancerNCT04468113Kliniken Essen-Mitte339